Regulatory Filings • Mar 2, 2015
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
C002����� ��"�2PublicEVOGENE LTD10571Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: [email protected] via MAGNA: 02/03/2015 Time of broadcast: 14:19 12:56:00
| Company site: | www.evogene.com |
Reference: 2015-02-042235
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Evogene's presentation to investors - March 2015 |
| Intro_to_Evogene_presentation_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 12/01/2015 |
| - - - |
| Name of the Signatory: : Masliah Sassi , Position of Signatory in the reporting corporation: Adv., Corporate Secretary , Name of Employer Company: . |
| Eizenberg Aharon Telephone: 08-9311971 , Facsimile: 08-9466724 , E-mail: [email protected] 1 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.